Exploitation & clinical-adoption partner for AI predictive biomarkers in chronic NCDs (HLTH-2027-02-TOOL-01)

AxioTechBio is looking to join a consortium preparing a proposal for HORIZON-HLTH-2027-02-TOOL-01-two-stage (predictive biomarkers of disease progression and treatment response using AI, non-cancer chronic NCDs; stage 1 deadline 17 February 2027).

The topic requires an exploitation plan prioritising the EU and encourages SME participation. AxioTechBio can contribute:

– Exploitation plan and route to clinical adoption of the biomarker signatures and decision-support tools

– Market analysis, end-user needs and business model, with clinicians and hospital laboratories in France and Spain

– Market & Procurement Readiness Kit: exploitable results map, FR/ES market sizing, public procurement map (buyers, procedures, tender calendars, award criteria), go-to-market and sustainability plan

– Industry-facing dissemination

– Commercial and end-user input to the consortium's regulatory strategy, led by specialised partners

– Industry bridge: access to a broad and growing network of European SMEs in omics, molecular diagnostics, bioinformatics and digital health

– Support to consortium building

Looking for:

– Clinical or academic coordinators with patient cohorts in chronic non-cancer diseases (e.g. liver, cardiovascular, metabolic, renal, respiratory, musculoskeletal or neurodegenerative)

– SMEs from across Europe with biomarker, diagnostic or AI technologies seeking a consortium or an exploitation partner

– Data and AI partners building multimodal biomarker platforms

– Clinical research centres in France and Spain with cohorts or real-world data to contribute

– Partners with regulatory (IVDR) and biomarker qualification expertise

Why AxioTechBio:

– We execute, not only plan: nearly 20 years selling genomics and diagnostics to hospitals and research centres

– Hands-on public procurement experience in France and Spain

– Post-project route to market: we can commercially represent the exploitable results in France and Spain

– We bring industry: a network of European omics and diagnostics SMEs